SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | ¥869.00 | 2 | |
一种抗糖尿病药物,可调节葡萄糖代谢,可能影响与 SDR16C6 相关的通路。 | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | ¥1726.00 ¥13809.00 ¥138080.00 | 82 | |
胰岛素是葡萄糖和脂质代谢的关键调节因子,可能会间接影响 SDR16C6 的活性。 | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | ¥609.00 ¥1388.00 | 13 | |
PPARγ 激动剂,影响脂质和葡萄糖代谢,可能对 SDR16C6 产生影响。 | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | ¥1331.00 ¥3610.00 ¥7017.00 ¥10470.00 ¥13922.00 | 38 | |
另一种 PPARγ 激动剂会改变脂质和葡萄糖代谢,从而影响 SDR16C6。 | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | ¥2505.00 ¥6690.00 | 1 | |
一种α-葡萄糖苷酶抑制剂,影响碳水化合物代谢,可能会影响 SDR16C6。 | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | ¥451.00 | 9 | |
作为 PPARα 激动剂,非诺贝特可调节脂质代谢,从而可能影响 SDR16C6。 | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | ¥688.00 ¥1376.00 | 1 | |
影响脂质代谢,可能影响 SDR16C6 相关途径。 | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | ¥2843.00 ¥5585.00 | 9 | |
他汀类药物会影响胆固醇代谢,从而可能影响 SDR16C6。 | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | ¥575.00 | 7 | |
抑制脂肪酶,影响脂质的消化和吸收,可能影响 SDR16C6。 |